Recent Advances in Neuroimaging of Mood Disorders: Structural and Functional Neural Correlates of Depression, Changes with Therapy, and Potential for Clinical Biomarkers

Current Treatment Options in Psychiatry

Volumn 1, Issue 3, 2014, Pages 278-293

  Atkinson, Lauren ^a   Sankar, Anjali ^b   Adams, Tracey M ^c   Fu, Cynthia H Y ^b,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c WARNEFORD HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

Antidepressive agents; Biological markers; Cognitive behavioural treatment; Depressive disorder; Emotions; Magnetic resonance imaging

Indexed keywords

EID: 84993678622     PISSN: None     EISSN: 21963061     Source Type: Journal    
DOI: 10.1007/s40501-014-0022-5     Document Type: Review

References (119)

1. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448–57.
2. The World Health Report 2000: Health Systems: Improving Performance. World Health Organization, 2000.
3. Ruhe HG, Booij J, Veltman DJ, Michel MC, Schene AH. Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. J Clin Psychiatry. 2012;73(4):451–9.
4. Fu CH, Mourao-Miranda J, Costafreda SG, Khanna A, Marquand AF, Williams SC, et al. Pattern classification of sad facial processing: toward the development of neurobiological markers in depression. Biol Psychiatry. 2008;63(7):656–62.First publication to identify potential of neural correlates for diagnosis and prognosis in depression with the application of machine learning methods to develop markers with high accuracy at the level of the individual.
5. Fu CH, Costafreda SG. In Review Neuroimaging-Based Biomarkers in Psychiatry: Clinical Opportunities of a Paradigm Shift. Can J Psychiat. 2013;58(9):499–508. [Class IV] This article examines recent findings on neural biomarkers in psychiatry and its potential clinical applications. This review focusses on machine learning-based approaches to identifying clinical biomarkers; and discusses the clinical opportunities and challenges in developing biomarkers for psychiatric disorders in the absence of a diagnostic gold standard.
6. Fu CH, Steiner H, Costafreda SG. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis. 2013;52:75–83. [Class I] This is the only comprehensive meta-analysis performed to date that has examined both structural and functional neuroimaging based biomarkers of clinical response to psychotherapy and antidepressant medication in depression.
7. Nouretdinov I, Costafreda SG, Gammerman A, Chervonenkis A, Vovk V, Vapnik V, et al. Machine learning classification with confidence: application of transductive conformal predictors to MRI-based diagnostic and prognostic markers in depression. Neuroimage. 2011;56(2):809–13.
8. Atkinson L. Grey matter abnormalities in Major Depressive Disorder: An updated meta-analysis of voxel-based morphometry studies. Unpublished master’s thesis, Institute of Psychiatry. Kings College London, London, United Kingdom, 2012.
9. Caetano SC, Kaur S, Brambilla P, Nicoletti M, Hatch JP, et al. Smallercingulate volumes in unipolar depressed patients. Biol Psychiatry. 2006;59:702–6.
10. Yucel K, McKinnon MC, Chahal R, Taylor VH, Macdonald K, et al. Anterior Cingulate Volumes in Never Treated Patients with Major Depressive Disorder. Neuropsychopharmacol. 2008;33:3157–63.
11. Tang Y, Wang F, Xie G, Liu J, Li L, et al. Reduced ventral anterior cingulate and amygdala volumes in medication-naïve females with major depressive disorder: A voxel-based morphometric magnetic resonance imaging study. Psychiat Res. 2007;156:83–6.
12. Lai CH, Hsu YY, Wu YT. First episode drug-naïve major depressive disorder with panic disorder: Gray matter deficits in limbic and default network structures. Eur Neuropsychopharmacol. 2010;20:676–82.
13. Bora E, Fornito A, Pantelis C, Yücel M. Gray matter abnormalities in Major Depressive Disorder: A meta-analysis of voxel-based morphometry studies. J Affect Disord. 2012;138:9–18.
14. Amico F, Meisenzahl E, Koutsouleris N, Reiser M, Möller HJ, et al. Structural MRI correlates for vulnerability and resilience to major depressive disorder. J Psychiatry Neurosci. 2011;36(1):15–22.
15. Lai CH. Gray matter volume in major depressive disorder: a meta-analysis of voxel-based morphometry studies. Psychiatry Res. 2013;211(1):37–46.
16. Anand A, Li Y, Wang Y, Wu J, Gao S, et al. Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsychopharmacol. 2005;30(7):1334–44.
17. Ho TC, Yang G, Wu J, Cassey P, Brown SD, et al. Functional connectivity of negative emotional processing in adolescent depression. J Affect Disord. 2014;155:65–74.
18. Matthews SC, Strigo IA, Simmons AN, Yang TT, Paulus MP. Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. J Affect Disord. 2008;111(1):13–20.
19. Costafreda SG, McCann P, Saker P, Cole J, Cohen-Woods S, et al. Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnosis. J Affect Disord. 2013;150:96–103.
20. Hamilton JP, Siemer M, Gotlib IH. Amygdala volume in Major Depressive Disorder: A meta-analysis of magnetic resonance imaging studies. Mol Psychiatr. 2008;13:993–1000.
21. Kong L, Chen K, Womer F, Jiang W, Luo X, et al. Sex differences of gray matter morphology in cortico-limbic-striatal neural system in major depressive disorder. J Psychiatr Res. 2013;47(6):733–9.
22. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, et al. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry. 2001;50(9):651–8.
23. Davidson RJ, Irwin W, Anderle MJ, Kalin NH. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry. 2003;160:64–75.
24. Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiat. 2004;61(9):877–89.
25. Kong L, Chen K, Tang Y, Wu F, Driesen N, et al. Functional connectivity between the amygdala and prefrontal cortex in medication-naive individuals with major depressive disorder. J Psychiatry Neurosci. 2013;38(6):417–22.
26. Veer IM, Beckmann CF, van Tol MJ, Ferrarini L, Milles J, et al. Whole brain resting-state analysis reveals decreased functional connectivity in major depression. Front Syst Neurosci. 2010;4:41.
27. Wagner G, Koch K, Schachtzabel C, Reichenbach JR, Sauer H, et al. Enhanced rostral anterior cingulate cortex activation during cognitive control is related to orbitofrontal volume reduction in unipolar depression. J Psychiatry Neurosci. 2008;33(3):199–208.
28. Peng J, Liu J, Nie B, Li Y, Shan B, et al. Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: A voxel-based morphometry study. Eur J Radiol. 2011;80:395–9.
29. Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R, et al. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage. 2011;54:2643–51.
30. Lai CH, Wu YT. Frontal-insula gray matter deficits in first-episode medication-naïve patients with major depressive disorder. J Affect Disord. 2014;160:74–9.
31. Kong L, Wu F, Tang Y, Ren L, Kong D, et al. Frontal-Subcortical Volumetric Deficits in Single Episode, Medication-Naïve Depressed Patients and the Effects of 8 Weeks Fluoxetine Treatment: A VBM-DARTEL Study. PLoS ONE. 2014;9(1):e79055.
32. Zhao YJ, Du MY, Huang XQ, Lui S, Chen ZQ, et al. Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis. Psychol Med. 2014. doi:10.1017/S0033291714000518.
33. Wu F, Tang Y, Xu K, Kong L, Sun W, et al. White matter abnormalities in medication-naive subjects with a single short-duration episode of major depressive disorder. Psychiatry Res. 2011;191:80–3.
34. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry. 2003;54(5):515–28.
35. Scheuerecker J, Meisenzahl EM, Koutsouleris N, Roesner M, Schöpf V, et al. Orbitofrontal volume reductions during emotion recognition in patients with major depression. J Psychiatry Neurosci. 2010;35(5):311–20.
36. Frodl T, Bokde AL, Scheuerecker J, Lisiecka D, Schöpf V, et al. Functional connectivity bias of the orbitofrontal cortex in drug-free patients with major depression. Biol Psychiatry. 2010;67:161–7.
37. Zhang X, Zhu X, Wang X, Zhu X, Zhong M, et al. First-episode medication-naive major depressive disorder is associated with altered resting brain function in the affective network. PLoS ONE. 2014;9(1):e85241. doi:10.1371/journal.pone.0085241.
38. Kempton MJ, Salvador Z, Munafò MR, Geddes JR, Simmons A, et al. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiat. 2011;68(7):675–90.
39. Cole J, Costafreda SG, McGuffin P, Fu CH. Hippocampal atrophy in first episode depression: A meta-analysis of magnetic resonance imaging studies. J Affect Disord. 2011;134:483–7.
40. aan het Rot M, Mathew SJ, Charney DS. Neurobiological mechanisms in major depressive disorder. Can Med Assoc J. 2009;180:305–13.
41. Zhang X, Yao S, Zhu X, Wang X, Zhong M. Gray matter volume abnormalities in individuals with cognitive vulnerability to depression: a voxel based morphometry study. J Affect Disord. 2012;136:443–52.
42. Costafreda SG, Chu C, Ashburner J, Fu CHY. Prognostic and diagnostic potential of the structural neuroanatomy of depression. PLoS ONE. 2009;44(7):e6353.
43. Sliz D, Hayley S. Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research. Front Hum Neurosci. 2012;6:323.
44. Avery JA, Drevets WC, Moseman SE, Bodurka J, Barcalow JC, et al. Major Depressive Disorder Is Associated with Abnormal Interoceptive Activity and Functional Connectivity in the Insula. Biol Psychiatry. 2013. doi:10.1016/j.biopsych.2013.11.027.
45. Malykhin NV, Carter R, Seres P, Coupland NJ. Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. J Psychiatry Neurosci. 2010;35:337–43.
46. Arnone D, McKie S, Elliott R, Juhasz G, Thomas EJ, Downey D, et al. State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry. 2013;18(12):1265–72. doi:10.1038/mp.2012.150. This is a recent article suggesting that reduced hippocampal grey matter volume may be involved in the aetiology of depression and risk of relapse.
47. Frodl T, Jäger M, Smajstrlova I, Born C, Bottlender R, Palladino T, et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci. 2008;33(5):423–30.
48. Kraus C, Ganger S, Losak J, Hahn A, Savli M, Kranz GS, et al. Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake. Neuroimage. 2014;84:236–44. doi:10.1016/j.neuroimage.2013.08.036.
49. Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. J Neuropsychiatry Clin Neurosci. 2000;12:103–13.
50. Zola SM, Squire LR, Teng E, Stefanacci L, Buffalo EA, Clark RE. Impaired recognition memory in monkeys after damage limited to the hippocampal region. J Neurosci. 2000;20:451–63.
51. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci. 1999;19:5034–43.
52. Cassano GB, Puca F, Scapicchio PL, Trabucchi M. Paroxetine and fluoxetine effects on mood and cognitive functions in depressed non-demented elderly patients. J Clin Psychiatry. 2002;63:396–402.
53. Levkovitz Y, Caftori R, Avital A, Richter-Levin G. The SSRIs drug Fluoxetine but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression. Brain Res Bull. 2002;58:345–50.
54. Vythilingam M, Vermetten E, Anderson GM, et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry. 2004;56:101–12.
55. Janssen J, Hulshoff Pol HE, Schnack HG, Kok RM, Lampe IK, et al. Cerebral volume measurements and subcortical white matter lesions and short term treatment response in late life depression. Int J Geriatr Psychiatry. 2007;22:468–74.
56. Smith R, Chen K, Baxter L, Fort C, Lane RD. Corrigendum to “Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex”. J Affect Disord. 2013;162:114–5.
57. Persad SM, Polivy J. Differences between depressed and nondepressed individuals in the recognition of and response to facial emotional cues. J Abnorm Psychol. 1993;102(3):358.
58. Surguladze S, Brammer MJ, Keedwell P, Giampietro V, Young AW, Travis MJ, et al. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry. 2005;57(3):201–9.
59. Costafreda SG, Brammer MJ, David AS, Fu CH. Predictors of amygdala activation during the processing of emotional stimuli: a meta-analysis of 385 PET and fMRI studies. Brain Res Rev. 2008;58(1):57–70.
60. Fu CH, Williams SC, Cleare AJ, Scott J, Mitterschiffthaler MT, Walsh ND, et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry. 2008;64(6):505–12.
61. Frodl T, Scheuerecker J, Schoepf V, Linn J, Koutsouleris N, Bokde AL, et al. Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. J Clin Psychiat. 2011;72(4):448.
62. Arnone D, McKie S, Elliott R, Thomas EJ, Downey D, Juhasz G, et al. Increased amygdala responses to sad but not fearful faces in major depression: relation to mood state and pharmacological treatment. Am J Psychiatry. 2012;169(8):841–50.
63. Fu C, Williams S, Brammer M, Suckling J, Kim J, Cleare A, et al. Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry. 2007;164(4):599–607.
64. Anand A, Li Y, Wang Y, Gardner K, Lowe M. Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study. J Neuropsychiatry Clin Neurosci. 2007;19(3):274–82.
65. Iidaka T, Omori M, Murata T, Kosaka H, Yonekura Y, Okada T, et al. Neural interaction of the amygdala with the prefrontal and temporal cortices in the processing of facial expressions as revealed by fMRI. J Cognitive Neurosci. 2001;13(8):1035.
66. Adolphs R. Neural systems for recognizing emotion. Curr Opin Neurobiol. 2002;12(2):169–77.
67. Chen CH, Suckling J, Ooi C, Fu CH, Williams SC, Walsh ND, et al. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacol. 2007;33(8):1909–18.
68. Groenewold NA, Opmeer EM, de Jonge P, Aleman A, Costafreda SG. Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies. Neurosci Biobehav Rev. 2013;37(2):152–63.
69. Jiang W, Yin Z, Pang Y, Wu F, Kong L, Xu K. Brain functional changes in facial expression recognition in patients with major depressive disorder before and after antidepressant treatment A functional magnetic resonance imaging study. Neural Regener Res. 2012;7(15):1151–7.
70. Duncan J, Owen AM. Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci. 2000;23(10):475–83.
71. Wagner G, Sinsel E, Sobanski T, Köhler S, Marinou V, Mentzel HJ, et al. Cortical inefficiency in patients with unipolar depression: an event-related FMRI study with the Stroop task. Biol Psychiatry. 2006;59(10):958–65.
72. Mitterschiffthaler M, Williams S, Walsh N, Cleare A, Donaldson C, Scott J, et al. Neural basis of the emotional Stroop interference effect in major depression. Psychol Med. 2008;38(2):247.
73. Wagner G, Koch K, Schachtzabel C, Sobanski T, Reichenbach JR, Sauer H, et al. Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. J Psychiatry Neurosci JPN. 2010;35(4):247.
74. Chen CH, Ridler K, Suckling J, Williams S, Fu CH, Merlo-Pich E, et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry. 2007;62(5):407–14.
75. Lisiecka D, Meisenzahl E, Scheuerecker J, Schoepf V, Whitty P, Chaney A, et al. Neural correlates of treatment outcome in major depression. Int J Neuropsychopharmacol. 2011;14(4):521.
76. Kringelbach ML. The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci. 2005;6(9):691–702.
77. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiat. 2005;62:409–16.
78. Beck AT, Shaw B, Rush J, Emery G. Cognitive Therapy for Depression. New York: Guildford Press; 1979.
79. Ritchey M, Dolcos F, Eddington KM, Strauman TJ, Cabeza R. Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response. J Psychiat Res. 2011;45(5):577–87.
80. Yoshimura S, Okamoto Y, Onoda K, Matsunaga M, Okada G, Kunisato Y, et al. Cognitive behavioral therapy for depression changes medial prefrontal and ventral anterior cingulate cortex activity associated with self-referential processing. Soc Cogn Affect Neurosci. 2014;9(4):487–93. doi:10.1093/scan/nst009.
81. Kelley WM, Macrae CN, Wyland CL, Caglar S, Inati S, Heatherton TF. Finding the self? An event-related fMRI study. J Cognitive Neurosci. 2002;14(5):785–94.
82. Nolen-Hoeksema S, Wisco BE, Lyubomirsky S. Rethinking rumination. Perspect Psychol Sci. 2008;3(5):400–24.
83. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiat. 2004;61(1):34–41.
84. Clark DA, Beck AT. Cognitive theory and therapy of anxiety and depression: Convergence with neurobiological findings. Trends Cogn Sci. 2010;14:418–24.
85. Harmer C, O’Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reineck A, et al. Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry. 2009;166:1178–84. Findings have important implications for early effects of antidepressant treatment on neural correlates of depression.
86. Harmer C, Heinzen J, O’Sullivan U, Ayres R, Cowen P. Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers. J Psychopharmacol. 2008;199:495–502.
87. Kennedy S, Konarski J, Segal Z, Lau M, Bieling P, McIntyre R, et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry. 2007;164(5):778–88.
88. Konarski JZ, Kennedy SH, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, et al. Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci: JPN. 2009;34(3):175.
89. Keedwell PA, Drapier D, Surguladze S, Giampietro V, Brammer M, Phillips M. Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression. J Affect Disord. 2010;120(1):120–5.
90. Marquand AF, Mourão-Miranda J, Brammer MJ, Cleare AJ, Fu CH. Neuroanatomy of verbal working memory as a diagnostic biomarker for depression. Neuroreport. 2008;19(15):1507–11.
91. Costafreda SG, Khanna A, Mourao-Miranda J, Fu CH. Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression. Neuroreport. 2009;20(7):637–41.
92. Gong Q, Wu Q, Scarpazza C, Lui S, Jia Z, Marquand A, et al. Prognostic prediction of therapeutic response in depression using high-field MR imaging. Neuroimage. 2011;55(4):1497–503.
93. Abe O, Yamasue H, Kasai K, Yamada H, Aoki S, et al. Voxel-based analyses of gray/white matter and diffusion tensor data in major depression. Psychiatry Res. 2010;181:64–70.
94. Avila R, Ribeiz S, Duran FLS, Arrais JPJ, Moscoso MAA, et al. Effect of temporal lobe structure volume on memory in elderly depressed patients. Neurobiol Aging. 2011;32:1857–67.
95. Bergouignan L, Chupin M, Czechowska Y, Kinkingnéhun S, Lemogne C, Le Bastard G, et al. Can voxel-based morphometry, manual segmentation, and automated segmentation equally detect hippocampal volume differences in acute depression? Neuroimage. 2009;45:29–37.
96. Cheng Y, Xu J, Chai P, Li H, Luo C, Yang T, et al. Brain volume alteration and the correlations with the clinical characteristics in drug-naïve first-episode MDD patients: A voxel-based morphometry study. Neurosci Lett. 2010;480:30–4.
97. Egger K, Schocke M, Weiss E, Auffinger S, Esterhammer R, Goebel G, et al. Pattern of brain atrophy in elderly patients with depression revealed by voxel-based morphometry. Psychiatry Res. 2008;164:237–44.
98. Frodl T, Koutsouleris N, Bottlender R, Born C, Jäger M, Mörgenthaler M, et al. Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry. 2008;13:1093–101.
99. Hwang J, Lee T, Tsai S, Chen T, Yang C, Lirng J, et al. Cortical and subcortical abnormalities in late-onset depression with history of suicide attempts investigated with MRI and voxel-based morphometry. J Geriatr Psychiatry Neurol. 2010;23(3):171–84.
100. Inkster B, Rao AW, Ridler K, Nichols TE, Saemann PG, Auer D, et al. Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms. J Neuroimaging. 2011;21(4):375–82.
101. Kim MJ, Hamilton JP, Gotlib IH. Reduced caudate gray matter volume in women with major depressive disorder. Psychiatry Res. 2008;164:114–22.
102. Koolschijn PC, van Haren NE, Schnack HG, Janssen J, Hulshoff Pol HE, Kahn RS. Cortical thickness and voxel-based morphometry in depressed elderly. Eur Neuropsychopharmacol. 2010;20:398–404.
103. Lee KH, Tae WS, Yoon H, Lee B, Paik J, Son K, et al. Demonstration of decreased gray matter concentration in the midbrain encompassing the dorsal raphe nucleus and the limbic subcortical regions in major depressive disorder: An optimized voxel-based morphometry study. J Affect Disord. 2011;133:128–36.
104. Leung KK, Lee TM, Wong MM, Li LS, Yip PS, Khong PL. Neural correlates of attention biases of people with major depressive disorder: a voxel-based morphometric study. Psychol Med. 2009;39:1097–106.
105. Li CT, Lin CP, Chou KH, Chen IY, Hsieh JC, Wu CL, et al. Structural and cognitive deficits in remitting and non-remitting recurrent depression: A voxel-based morphometric study. Neuroimage. 2010;50:347–56.
106. Mak AKY, Wong MMC, Han SH, Lee TMC. Gray matter reduction associated with emotion regulation in female outpatients with major depressive disorder: A voxel-based morphometry study. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1184–90.
107. Mwangi B, Ebmeier KP, Matthews K, Steele D. Multi-centre diagnostic classification of individual structural neuroimaging scans from patients with major depressive disorder. Brain. 2012;135:1508–21.
108. Pizzagalli DA, Oakes TR, Fox AS, Chung MK, Larson CL, Abercrombie HC, et al. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol Psychiatry. 2004;9:393–405.
109. Ries ML, Wichmann A, Bendlin BB, Johnson SC. Posterior cingulate and lateral parietal gray matter volume in older adults with depressive symptoms. Brain Imaging Behav. 2009;3:233–9.
110. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry. 1998;172:527–32.
111. Soriano-Mas C, Hernández-Ribas R, Pujol J, Urretavizcaya M, Deus J, Harrison BJ. Cross-sectional and longitudinal assessment of structural brain alterations in melancholic depression. Biol Psychiatry. 2011;69:318–25.
112. Treadway MT, Grant MM, Ding Z, Hollon SD, Gore JC, Shelton RC. Early Adverse Events, HPA Activity and Rostral Anterior Cingulate Volume in MDD. PLoS ONE. 2009;4(3):e4887.
113. Taki Y, Kinomura S, Awata S, Inoue K, Sato K, Ito H, et al. Male elderly subthreshold depression patients have smaller volume of medial part of prefrontal cortex and precentral gyrus compared with age-matched normal subjects: A voxel-based morphometry. J Affect Disord. 2005;88(3):313–20.
114. van Tol M, van der Wee N, van den Heuvel O, Nielen M, Demenescu L, Aleman A, et al. Regional brain volume in depression and anxiety disorders. Arch Gen Psychiatry. 2010;67(10):1002–11.
115. Vasic N, Walter H, Höse A, Wolf RC. Gray matter reduction associated with psychopathology and cognitive dysfunction in unipolar depression: A voxel-based morphometry study. J Affect Disord. 2008;109:107–16.
116. Wagner G, Koch K, Schachtzabel C, Schultz CC, Sauer H, Schlösser RGM. Structural brain alterations in patients with major depressive disorder and high risk for suicide: Evidence for a distinct neurobiological entity? Neuroimage. 2011;54:1607–14.
117. Yuan Y, Zhu W, Zhang Z, Bai F, Yu H, Shi Y, et al. Regional gray matter changes are associated with cognitive deficits in remitted geriatric depression: An optimized voxel-based morphometry study. Biol Psychiatry. 2008;64:541–4.
118. Zhang TJ, Wu QZ, Huang X-Q, Sun XL, Zou K, Lui S, et al. Magnetization transfer imaging reveals the brain deficit in patients with treatment-refractory depression. J Affect Disord. 2009;117:157–61.
119. Zou K, Deng W, Li T, Zhang B, Jiang L, Huang C, et al. Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: An optimized voxel-based morphometry study. Biol Psychiatry. 2010;67:186–8.